The non-canonical NF-κB pathway is also aberrantly dysregulated in DLBCL, as 10–15% of GCB- and ABC-DLBCL carry genetic lesions in TRAF2 and TRAF3 associated with an activation of this pathway [49]. Here, NFKB1 is linked to diffuse large B-cell lymphoma.